drugset
drugset / Trial / NCT04314661

Mesenchymal Stem Cell Therapy (MSCs) and Conditioned Medium Therapy for Osteoartrithis

NCT04314661 ↗

Phase 1/2 Completed 31 enrolled PT. Prodia Stem Cell Indonesia
RandomizedParallel-groupOpen-labelTreatment

Summary

This study aims to compare the efficacy of Umbilical Cord Mesenchymal Stem Cell and secretome between arthroscopy and without arthroscopy intervention in OA patients. This study has 4 arms namely Arthroscopy + Booster, Arthroscopy + Pre-conditioning, Non-Arthroscopy + Booster, Non-Arthroscopy + Pre-conditioning.

Timeline

Start
2020-08-03
Primary completion
2024-07-08
Completion
2024-12-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Secretome Other / unclassified 2 ml Other
Subject mesenchymal stem cells Cell therapy 1e+07 cells Other

Indications

osteoarthritis, knee